• ProMIS Neurosciences Announces US$15 Million Offering of Units firstwordpharma
    August 18, 2021
    ProMIS has filed today a preliminary prospectus supplement (the "Supplement") to its final short form base shelf prospectus dated June 30, 2021 (the "Base Prospectus") in connection with a proposed commercially reasonable efforts public offering.
PharmaSources Customer Service